EUVIMEDEUVIMED entdecken
Crossref

Plasma Proteomic High-Performance Biomarkers for Early Diagnosis of Colorectal Cancer

Haoran Jin iD, Kai Deng, Shaochong Qi, Zhaomin Deng, Lu Pu, Dongqin Xu, Weina Jing, Jin Wang, Zhiliang Zuo, Jinlin Yang, Hao Jiang

Journal of Proteome Research · 2025

DOI: 10.1021/acs.jproteome.5c00483 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Proteome Research, 2025. Verfasst von Haoran Jin und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology and Hepatology, West China Hospital, Sichuan University, Chengdu 610041, China. Hauptthemen laut MEDLINE: Colorectal Neoplasms, Biomarkers, Tumor, Early Detection of Cancer, Proteomics. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 56 Literaturangaben. Gefördert von: West China Hospital, Sichuan University, National Key Research and Development Program of China, Science and Technology Department of Sichuan Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Colorectal cancer (CRC) is a major global health challenge due to its high incidence, mortality, and low rate of early detection. Early diagnosis, targeting precancerous lesions (advanced adenomas) and early stage CRC (Tis and T1), is critical for improving patient survival. Given the limitations of current detection methods for advanced adenomas, developing high-performance early diagnostic strategies is essential for effective prevention. In this study, we employed the proximity extension assay using the Olink Explore 384 Cardiometabolic panel to identify 15 protein biomarkers, of which 8 proteins (MMP7, GDF15, REG1B, RNASE3, REG1A, TFF3, MFAP5, and TGM2) were incorporated into multiple machine learning models to diagnose colorectal advanced neoplasia (AN) in the discovery cohort (n = 80), achieving AUC values above 0.90. These models also demonstrated significant diagnostic performance, with AUCs greater than 0.88, for patients with AN or advanced adenomas in the validation cohort (n = 69). Furthermore, hub biomarkers (MMP7 and GDF15) were identified and subsequently validated along with an analysis of their clinical significance. Thus, our study identifies multiprotein signatures validated in two cohorts with high diagnostic performance for colorectal AN, contributing to the development of the clinical detection kit for noninvasive early diagnosis of CRC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Colorectal NeoplasmsBiomarkers, TumorEarly Detection of CancerProteomicsAdenomaHumansMaleFemaleMiddle AgedGrowth Differentiation Factor 15AgedMatrix Metalloproteinase 7Machine Learning

Stichwörter der Autor:innen

PEAadvanced adenomaadvanced neoplasiacolorectal cancerdiagnosis biomarker

Substanzen

Biomarkers, TumorGrowth Differentiation Factor 15GDF15 protein, humanMatrix Metalloproteinase 7MMP7 protein, human

Autor:innen und Institutionen

  • Department of Gastroenterology and Hepatology, West China Hospital, Sichuan University, Chengdu 610041, China.
  • Sichuan University-University of Oxford Huaxi Joint Centre for Gastrointestinal Cancer, Frontiers Science Center for Disease-Related Molecular Network, West China Hospital, Sichuan University, Chengdu 610041, China.
  • The Quzhou Affiliated Hospital of Wenzhou Medical University, Quzhou People's Hospital, Quzhou 324000, China.
  • Laboratory for Aging and Cancer Research, National Clinical Research Center for Geriatrics and State Key Laboratory of Respiratory Health and Multimorbidity, West China Hospital, Sichuan University, Chengdu 610041, Chin…
  • Laboratory of Aging and Cancer, Frontiers Science Center for Disease-related Molecular Network, West China Hospital, Sichuan University, Chengdu 610041, China.
  • Center of Gerontology and Geriatrics, National Clinical Research Center for Geriatrics, West China Hospital, Sichuan University, Chengdu 610041, Sichuan, China.

ORCID-Profile: Haoran Jin

Förderung

  • West China Hospital, Sichuan University
  • National Key Research and Development Program of China
  • Science and Technology Department of Sichuan Province
  • National Natural Science Foundation of China
  • Excellent Young Scientists Fund

Zitieren

APA

Jin, H., Deng, K., Qi, S., Deng, Z., Pu, L., Xu, D., Jing, W., Wang, J., Zuo, Z., Yang, J., & Jiang, H. (2025). Plasma Proteomic High-Performance Biomarkers for Early Diagnosis of Colorectal Cancer. Journal of Proteome Research. https://doi.org/10.1021/acs.jproteome.5c00483

Vancouver

Jin H, Deng K, Qi S, Deng Z, Pu L, Xu D, et al. Plasma Proteomic High-Performance Biomarkers for Early Diagnosis of Colorectal Cancer. Journal of Proteome Research. 2025. doi:10.1021/acs.jproteome.5c00483

BibTeX
@article{Jin2025,
  author = {Jin, Haoran and Deng, Kai and Qi, Shaochong and Deng, Zhaomin and Pu, Lu and Xu, Dongqin and Jing, Weina and Wang, Jin and Zuo, Zhiliang and Yang, Jinlin and Jiang, Hao},
  title = {Plasma Proteomic High-Performance Biomarkers for Early Diagnosis of Colorectal Cancer},
  journal = {Journal of Proteome Research},
  year = {2025},
  doi = {10.1021/acs.jproteome.5c00483}
}
Kostenlos starten →